HIF1A and prostate carcinoma: These pathways were predominantly related to proteoglycans in cancer, EGFR tyrosine kinase inhibitor resistance, pathways in cancer, prostate cancer, endocrine resistance, and the HIF-1 signaling pathway, among others.